HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity.

AbstractOBJECTIVE:
Evidence supports the role of dietary fiber in improving metabolic health. PolyGlycopleX (PGX), a viscous functional polysaccharide improves lipidemia and glycemia in healthy adults. Our objective was to examine the effects of PGX on risk factors associated with the metabolic syndrome in Japanese adults with abdominal obesity.
DESIGN AND METHODS:
Sixty four subjects assigned to 14 weeks of 15 g day(-1) of PGX or placebo were assessed in a randomized, double-blind, placebo-controlled, parallel group trial. At week 0 and 14, primary outcome measures were serum lipids, abdominal adiposity, glucose tolerance and blood pressure.
RESULTS:
Total and LDL cholesterol were reduced at week 14 with PGX but not placebo (P < 0.05). The reduction in waist circumference at week 14 was greater with PGX versus placebo (P < 0.05). In females, abdominal visceral fat was decreased to a greater extent with PGX versus placebo (P < 0.05). While glucose tolerance worsened with placebo over time, PGX reduced glucose total area under the curve from week 0 to 6 (P = 0.039). Serum concentrations of resistin and IL6 increased slightly in placebo and decreased slightly with PGX .
CONCLUSIONS:
PGX is a functional fiber that shows promise in reducing risk factors related to the metabolic syndrome in Japanese adults with abdominal obesity.
AuthorsRaylene A Reimer, Hideyo Yamaguchi, Lindsay K Eller, Michael R Lyon, Roland J Gahler, Veronica Kacinik, Prateek Juneja, Simon Wood
JournalObesity (Silver Spring, Md.) (Obesity (Silver Spring)) Vol. 21 Issue 9 Pg. E379-87 (Sep 2013) ISSN: 1930-739X [Electronic] United States
PMID23512917 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 The Obesity Society.
Chemical References
  • Blood Glucose
  • Cholesterol, LDL
  • Dietary Fiber
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Interleukin-6
  • Polysaccharides
  • Resistin
  • Cholesterol
Topics
  • Adiposity
  • Adult
  • Aged
  • Asian People
  • Blood Glucose (metabolism)
  • Cholesterol (blood)
  • Cholesterol, LDL (blood)
  • Dietary Fiber (pharmacology, therapeutic use)
  • Double-Blind Method
  • Female
  • Glucose Intolerance (blood, etiology, prevention & control)
  • Humans
  • Hypoglycemic Agents (pharmacology, therapeutic use)
  • Hypolipidemic Agents (pharmacology, therapeutic use)
  • Interleukin-6 (blood)
  • Intra-Abdominal Fat (metabolism)
  • Male
  • Metabolic Syndrome (etiology, metabolism, prevention & control)
  • Middle Aged
  • Obesity, Abdominal (diet therapy, metabolism)
  • Polysaccharides (pharmacology, therapeutic use)
  • Resistin (blood)
  • Sex Factors
  • Viscosity
  • Waist Circumference
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: